A detailed history of Silvercrest Asset Management Group LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 589,305 shares of AXGN stock, worth $8.58 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
589,305
Previous 800,921 26.42%
Holding current value
$8.58 Million
Previous $5.8 Million 42.5%
% of portfolio
0.06%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $14.69 $1.59 Million - $3.11 Million
-211,616 Reduced 26.42%
589,305 $8.26 Million
Q2 2024

Aug 14, 2024

SELL
$5.67 - $8.06 $4.54 Million - $6.46 Million
-800,921 Reduced 50.0%
800,921 $5.8 Million
Q2 2024

Aug 14, 2024

BUY
$5.67 - $8.06 $4.6 Million - $6.54 Million
811,195 Added 102.6%
1,601,842 $11.6 Million
Q1 2024

May 15, 2024

BUY
$6.63 - $10.69 $228,065 - $367,725
34,399 Added 4.55%
790,647 $6.38 Million
Q4 2023

Feb 14, 2024

SELL
$3.61 - $7.76 $598,314 - $1.29 Million
-165,738 Reduced 17.98%
756,248 $5.17 Million
Q3 2023

Nov 14, 2023

SELL
$4.68 - $9.26 $11,110 - $21,983
-2,374 Reduced 0.26%
921,986 $4.61 Million
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $1.12 Million - $1.37 Million
131,790 Added 16.63%
924,360 $8.44 Million
Q1 2023

May 15, 2023

BUY
$7.53 - $10.95 $812,404 - $1.18 Million
107,889 Added 15.76%
792,570 $7.49 Million
Q4 2022

Feb 14, 2023

SELL
$9.44 - $13.09 $58,981 - $81,786
-6,248 Reduced 0.9%
684,681 $6.83 Million
Q3 2022

Nov 14, 2022

SELL
$8.14 - $12.25 $152,909 - $230,116
-18,785 Reduced 2.65%
690,929 $8.24 Million
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $223,141 - $319,230
-31,923 Reduced 4.3%
709,714 $5.81 Million
Q1 2022

May 16, 2022

BUY
$7.26 - $10.7 $1.33 Million - $1.96 Million
183,579 Added 32.9%
741,637 $5.89 Million
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $820,714 - $1.49 Million
93,263 Added 20.07%
558,058 $5.23 Million
Q3 2021

Nov 15, 2021

SELL
$15.23 - $21.72 $163,174 - $232,708
-10,714 Reduced 2.25%
464,795 $7.34 Million
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $2.64 Million - $3.49 Million
148,507 Added 45.41%
475,509 $10.3 Million
Q1 2021

May 17, 2021

BUY
$17.18 - $22.6 $5.62 Million - $7.39 Million
327,002 New
327,002 $6.63 Million
Q1 2020

May 15, 2020

SELL
$8.38 - $17.34 $2.86 Million - $5.92 Million
-341,342 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $164,122 - $273,048
-14,680 Reduced 4.12%
341,342 $6.11 Million
Q3 2019

Nov 14, 2019

BUY
$12.09 - $20.46 $4.3 Million - $7.28 Million
356,022 New
356,022 $4.44 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $616M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.